je.st
news
Tag: snubbing
Private investors back snubbing of PotashCorp.'s $8.6B takeover bid: K+S
2015-08-11 05:53:04| Chemicals - Topix.net
Norbert Steiner, CEO of K+S Group, says the PotashCorp takeover bid for K+S undervalues the Legacy mine, which is expected to begin production in 2017. K+S AG, which rejected an $8.6 billion takeover approach from Potash Corp. of Saskatchewan Inc., said both private and institutional shareholders back management's stance and agree the offer falls short.
Tags: back
private
bid
investors
Shire Snubbing AbbVie Makes It Latest Pharma Target: Real M&A
2014-06-21 22:12:30| Biotech - Topix.net
AbbVie Inc. earlier this week revealed a $46.5 billion takeover bid for Shire in the first public acquisition approach for the specialty drugmaker after years of takeover speculation.
Onyx Snubbing Amgen Paves Way for 89% Premium: Real M&A
2013-07-03 06:25:34| Biotech - Topix.net
Onyx Pharmaceuticals Inc. , which surged more than 50 percent after rejecting a bid from Amgen Inc., is betting that potential suitors from Bayer AG to Bristol-Myers Squibb Co.
Onyx Snubbing Amgen Paves Way for 89% Deal Premium: Real M&A
2013-07-02 19:26:33| Chemicals - Topix.net
Onyx Pharmaceuticals Inc., which surged more than 50 percent after rejecting a bid from Amgen Inc., is betting that potential suitors from Bayer AG to Bristol-Myers Squibb Co.
Sites : [1] [2]